-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JzMlWji4T3fCfVdSriw3sa1fAidTnQP67aUvPAGn5C4yZ2/kmUJJxTb4a/NtyPlt gnv1Oxn5Swh/13HygR1kgA== 0000902595-06-000073.txt : 20060728 0000902595-06-000073.hdr.sgml : 20060728 20060728145638 ACCESSION NUMBER: 0000902595-06-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060727 FILED AS OF DATE: 20060728 DATE AS OF CHANGE: 20060728 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP CENTRAL INDEX KEY: 0000702259 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 952802182 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3106458200 MAIL ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reith John H CENTRAL INDEX KEY: 0001311253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09957 FILM NUMBER: 06987713 BUSINESS ADDRESS: BUSINESS PHONE: 310-725-7039 MAIL ADDRESS: STREET 1: DIAGNOSTIC PRODUCTS CORPORATION STREET 2: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 4 1 jreith_form4ex.xml X0202 4 2006-07-27 1 0000702259 DIAGNOSTIC PRODUCTS CORP DP 0001311253 Reith John H C/O DIAGNOSTIC PRODUCTS CORPORATION 5210 PACIFIC CONCOURSE DRIVE LOS ANGELES CA 90045 1 0 0 0 Common Stock Option - Right to Buy 53.92 2006-07-27 4 D 0 10000 D 2015-01-04 Common Stock 10000 0 D Common Stock Option - Right to Buy 48.73 2006-07-27 4 D 0 5000 D 2013-02-15 Common Stock 5000 0 D 2,000 vested on January 4, 2006. 2,000 will vest annually on January 4, 2007 through January 4, 2010. Cancelled pursuant to the Agreement and Plan of Merger, dated as of April 26, 2006, by and among the issuer, Siemens Medical Solutions USA, Inc., and Dresden Acquisition Corporation (the "Merger Agreement") in exchange for an amount equal to $58.50 for each share of common stock of the issuer subject to the cancelled option, less the applicable exercise price and any applicable withholding taxes, the aggregate amount of which is payable in the form of cash. 1,000 will vest annually on February 15, 2007 through February 15, 2011. James L. Brill, Authorized Signer 2006-07-27 -----END PRIVACY-ENHANCED MESSAGE-----